Establishment Labs Holdings Inc.

WHO'M
ai
Digital Profiler. Einfach den AI-Button klicken
CUSIP

G31249108
SEDOL

BYVR2D4
CIK

0001688757

www.establishmentlabs.com
LEI:
Establishment Labs is a Member of Themefolio
          Hindenburg (TTF)          
FIGI: BBG00X1PG636
ESTA

Establishment Labs Holdings Inc.
GICS: - · Sektor: Healthcare · Sub-Sektor: Medical Devices
AI
PROFILER
NAME
Establishment Labs Holdings Inc.
ISIN
VGG312491084
TICKER
ESTA
MIC
XNAS
REUTERS
ESTA.OQ
BLOOMBERG
ESTA US
GIF DE 728x90
FÜR INVESTOREN
FÜR TRADER
Börsenhandel Warrants
Der X-News Explorer ist die ultimative Informationsquelle für börsenaffine Anleger, die sich schnell und komfortabel einen Überblick über die aktuelle Nachrichtenlage eines börsennotierten Unternehmens verschaffen möchten. Ihnen stehen hier verschiedene Newswire-Services zur Verfügung. Wird ein News-Alert angezeigt, liegen Unternehmensnachrichten vor, die Sie möglicherweise interessieren könnten. Dieser Service wird Ihnen von BusinessWire bereitgestellt.
Mo., 11.11.2024       Establishment Labs
VGG312491084

Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women’s health and wellness, principally in breast aesthetics and reconstruction, today announced its participation in three upcoming investment conferences. Juan José Chacón-Quirós, Chief Executive Officer and Founder, and Raj Denhoy, Chi...
Do., 07.11.2024       Establishment Labs
VGG312491084

Establishment Labs Holdings Inc. (Nasdaq: ESTA) (the “Company”), a global medical technology company dedicated to improving women’s health and wellness, principally in breast aesthetics and reconstruction, today announced that it has entered into a securities purchase agreement (the “Purchase Agreement”) with select purchasers for the purchase of ...
Do., 07.11.2024       Establishment Labs
VGG312491084

Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women’s health and wellness, principally in breast aesthetics and reconstruction, today announced financial results for the third quarter ended September 30, 2024. Third Quarter Highlights and Outlook Third quarter worldwide revenue of $4...
Do., 31.10.2024       Establishment Labs
VGG312491084

Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women’s health and wellness, principally in breast aesthetics and reconstruction, announced the presentation of three-year clinical results with Mia Femtech™ at the 9th Annual World Symposium on Ergonomic Implants (WSEI) being held this week...
Do., 24.10.2024       Establishment Labs
VGG312491084

Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women’s health and wellness, principally in breast aesthetics and reconstruction, plans to announce its financial results for the quarter ended September 30, 2024, after the market closes on Thursday, November 7, 2024, and will host a confer...
Di., 15.10.2024       Establishment Labs
VGG312491084

Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women’s health and wellness, principally in breast aesthetics and reconstruction, announced that it has published its 2024 Post Market Surveillance (PMS) Report. “It is fitting that as we publish our 2024 PMS report, we begin broadly shippi...
Mi., 02.10.2024       Establishment Labs
VGG312491084

Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women’s health and wellness, principally in breast aesthetics and reconstruction, announced today that the first patients in the United States have successfully undergone breast augmentation with Motiva® Implants. “With the FDA approval las...
Do., 26.09.2024       Establishment Labs
VGG312491084

Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women’s health and wellness, principally in breast aesthetics and reconstruction, announced it has received approval from the U.S. Food and Drug Administration (FDA) for the use of Motiva® SmoothSilk® Ergonomix® and Motiva® SmoothSilk® Round...
We are different
OPEN FINANCIAL
DATA & KNOWLEDGE HUB
We make the difference
Informationen zu Product Placements

 

SMART * AD
EN GIF 970X250

P R O D U C T   S U G G E S T I O N S